Testing effectiveness (Phase 2)WithdrawnNCT04386447
What this trial is testing
Phase II RCT to Assess Efficacy of Intravenous Administration of Oxytocin in Patients Affected by COVID-19
Who this might be right for
Covid-19Corona Virus InfectionSARS-CoV 2
Azienda Ospedaliero-Universitaria di Parma